HealthDay News — In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in ...
Vaccination effectiveness did not differ with inverse probability of vaccination weighting or for those aged 60 to 74 years and 75 years and older. HealthDay News — For older adults, respiratory ...
The World Health Organization on Tuesday recommended maternal vaccination and the use of an antibody therapy to prevent respiratory synctial virus (RSV) in infants.
Some results have been hidden because they may be inaccessible to you